Figure 2. Ordinal scale categories at consecutive time points during Delta (D) and Omicron (O) surges in all patients treated with remdesivir (A), in all patients treated with (RDV) or without antiviral treatment (NO AVT) during Delta (B) and Omicron (C) surges.
Regardless of which variant of SARS-CoV-2 the patients were infected with, RDV therapy reduced the risk of death (Figure 2, Table 4).
Table 4. Endpoints of hospitalized patients during Delta and Omicron waves with regard to RDV treatment.